VIRI -71% on phase-2b failure in fibromyalgia: https://finance.yahoo.com/news/virios-therapeutics-announces-top-line-110500583.html My comment from 12/16/20:...the company itself admits that such conditions as fibromyalgia are poorly understood, so who knows if Virios is even chasing the right targets.